脑部放疗，上午比下午敏感许多！
C( R H5 H, ?
* r) F+ s2 A3 M& m) K
$ l+ D0 O L' u/ `" G7 J1 w2 PCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
% `7 n: A% I# i1 ] Q$ F: ?Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?) W$ ` a0 b8 M. i7 V' @* w
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.7 Y0 Z$ K0 e" X/ `
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.1 |$ k5 m# |3 F G
6 |9 S: Q1 G# `9 \
Abstract
6 w% @! y; t6 U' a$ BBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
% M, w9 c7 l4 v$ I/ N7 V5 F/ h3 s& V
2 \4 s9 [# {2 s" Z* Z) yMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
+ Q* k1 F8 K* F2 _$ g- w( X# z8 s o! ?# A0 @0 M) j$ E8 w
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
/ r \4 v. ~# N% {* n: {: i* Y, G6 z% u5 k
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
6 y, S; l; O# w
4 o2 e5 z8 Z# z" z7 y' G& O" c |
9 i- y9 O1 _$ {6 g
显身卡
